Sheryl Anne D Vermudez

Years Active: 2021-2023
Publications (10 Years): 3

This page only lists publications with an associated author ORCID identifier.

Publications

Sameer C Dhamne, Meera E Modi, Audrey Gray, Simone Bonazzi, Lucas Craig, Elizabeth Bainbridge, Lahin Lalani, Chloe E Super, Samantha Schaeffer, Ketthsy Capre, Danuta Lubicka, Guiqing Liang, Doug Burdette, Stephanie M McTighe, Sarika Gurnani, Sheryl Anne D Vermudez, Daniel Curtis, Christopher J Wilson, Mustafa Q Hameed, Angelica D'Amore, Alexander Rotenberg, Mustafa Sahin
Seizure reduction in TSC2-mutant mouse model by an mTOR catalytic inhibitor. Annals of clinical and translational neurology (2023)
Mustafa Q Hameed, Benjamin Hui, Rui Lin, Paul C MacMullin, Andres Pascual-Leone, Sheryl Anne D Vermudez, Alexander Rotenberg
Depressed glutamate transporter 1 expression in a mouse model of Dravet syndrome. Annals of clinical and translational neurology (2023)
Sheryl Anne D Vermudez, Rocco G Gogliotti, Bright Arthur, Aditi Buch, Clarissa Morales, Yuta Moxley, Hemangi Rajpal, P Jeffrey Conn, Colleen M Niswender
Profiling beneficial and potential adverse effects of MeCP2 overexpression in a hypomorphic Rett syndrome mouse model. Genes, brain, and behavior (2021)

Sheryl Anne D Vermudez.css-eqlu8i{font-size:small;padding-left:4px;}